Inmune Bio (INMB) Total Current Liabilities (2018 - 2025)
Historic Total Current Liabilities for Inmune Bio (INMB) over the last 8 years, with Q3 2025 value amounting to $7.4 million.
- Inmune Bio's Total Current Liabilities fell 4677.71% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 million, marking a year-over-year decrease of 4677.71%. This contributed to the annual value of $7.2 million for FY2024, which is 6089.36% down from last year.
- Inmune Bio's Total Current Liabilities amounted to $7.4 million in Q3 2025, which was down 4677.71% from $8.6 million recorded in Q2 2025.
- Over the past 5 years, Inmune Bio's Total Current Liabilities peaked at $18.5 million during Q4 2023, and registered a low of $2.2 million during Q1 2021.
- In the last 5 years, Inmune Bio's Total Current Liabilities had a median value of $7.9 million in 2025 and averaged $9.0 million.
- Its Total Current Liabilities has fluctuated over the past 5 years, first soared by 47133.48% in 2023, then tumbled by 6089.36% in 2024.
- Inmune Bio's Total Current Liabilities (Quarter) stood at $4.4 million in 2021, then soared by 150.47% to $10.9 million in 2022, then soared by 69.12% to $18.5 million in 2023, then crashed by 60.89% to $7.2 million in 2024, then rose by 1.88% to $7.4 million in 2025.
- Its Total Current Liabilities stands at $7.4 million for Q3 2025, versus $8.6 million for Q2 2025 and $7.9 million for Q1 2025.